“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  SYK

STRYKER CORP

LISTEDNYSE
SYMBOLSYK
SIC3841
STATE OF INC.MI
FISCAL YEAR ENDSDecember 31
CIK310764

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions01020302016201720182019202020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share0.002.505.007.5010.002016201720182019202020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)Amount%
Total debt15,85941.4
Stockholders' equity22,42058.6
Total capitalization38,279100.0

383,573,046 shares outstanding at 30 June 2026 (cover page of the 10-Q filed 31 July 2026).

LONG-TERM DEBT 12/31/25

($ millions)Amount
Long-term debt, incl. current maturities15,859
Long-term debt, noncurrent14,859
Current maturities1,000
Short-term borrowings / commercial paper0

CAPITAL STOCK 12/31/25

Common shares authorized1,000,000,000
Par or stated value per share ($)0.1
Outstanding at 6/30/26383,573,046

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
2025––
2024––
2023––
2022––
2021––

HISTORY AND BUSINESS

HISTORY: Incorporated in Michigan.

BUSINESS: Classified by the SEC under Standard Industrial Classification 3841, Surgical & Medical Instruments & Apparatus. Large accelerated filer. Principal executive office: 1941 Stryker Way, Portage, MI 49002. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)12/31/2512/31/2412/31/23
Revenues25,11622,59520,498
Cost of revenues9,0518,1557,440
Gross profit16,06514,44013,058
Research and development1,6231,4661,388
Selling, general and administrative8,6517,6857,111
Depreciation and amortization1,5701,4261,341
Operating income4,8893,6893,888
Interest expense607409363
Income before income taxes4,5143,4923,673
Income taxes1,268499508
Net income3,2462,9933,165
Earned per share, diluted ($)8.407.768.25
Dividends per share ($)–––

CONSOLIDATED BALANCE SHEET

($ millions)12/31/2512/31/24
Cash and equivalents4,0113,652
Receivables, net4,0393,987
Inventories5,3104,774
Total current assets14,75514,847
Property, plant and equipment, net3,8763,448
Goodwill19,29115,855
Total assets47,84442,971
Total current liabilities7,7947,616
Long-term debt14,85912,188
Total liabilities25,42422,337
Total liabilities and equity47,84442,971

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
12/31/2525,1164,8893,24612.98.40–5,0447614,28347,84425,42415,85922,42014.50.71
12/31/2422,5953,6892,99313.27.76–4,2427553,48742,97122,33713,59720,63414.50.66
12/31/2320,4983,8883,16515.48.25–3,7115753,13639,91221,31912,99518,59317.00.70
12/31/2218,4492,8412,35812.86.17–2,6245882,03636,88420,26813,04816,61614.20.79
12/31/2117,1082,5841,99411.75.21–3,2635252,73834,63119,75412,47914,87713.40.84
12/31/2014,3512,2231,59911.14.20–3,2774872,79034,33021,24613,99113,08412.21.07
12/31/1914,8842,7132,08314.05.48–2,1916491,54230,16717,36011,09012,80716.30.87
12/31/1813,6012,5373,55326.19.34–2,6105722,03827,22915,4999,85911,73030.30.84
12/31/1712,4442,2971,0208.22.68–1,55959896122,19712,2177,2229,96610.20.72
12/31/1611,3252,1751,64714.54.351.561,9154901,42520,43510,8857,1149,55017.20.74

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

STRYKER CORP
CIK 310764 · EIN 38-1239739

PRINCIPAL OFFICE:

1941 Stryker Way, Portage, MI 49002
Tel.: 2693852600

INCORPORATED:

Michigan

INDUSTRY (SEC SIC CODE):

3841 · Surgical & Medical Instruments & Apparatus

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 11 February 2026

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

10/6/268-Kperiod 10/6/26
7/31/2610-Qperiod 6/30/26
7/30/268-Kperiod 7/30/26
6/26/268-Kperiod 6/26/26
5/20/268-Kperiod 5/15/26
5/11/2610-Qperiod 3/31/26
5/8/268-Kperiod 5/6/26
4/30/268-Kperiod 4/30/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/11/26) · 10-K FY2024 (filed 2/12/25) · 10-K FY2023 (filed 2/14/24) · 10-K FY2022 (filed 2/10/23) · 10-K FY2021 (filed 2/11/22) · 10-K FY2020 (filed 2/11/21) · 10-K FY2019 (filed 2/6/20) · 10-K FY2018 (filed 2/7/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice